Latest United States News

Union Star Metals ended September with A$220,000 in cash, enough for an estimated 0.44 quarters of funding at the quarter’s outflow rate. The company has completed its Brazilian asset sale and is pursuing portfolio disposals, but permitting delays have pushed back planned drilling at its main Nevada project.

DataDot Technology Limited (ASX:DDT) delivered a stronger FY26, with revenue rising 14.1% to $3.85 million and profit before tax nearly tripling to $327,420. The sharper result was driven largely by PropertyVAULT’s first full year of insurance services, although key insurer relationships remain pilots or works in progress.

Invex Therapeutics has agreed to acquire New Zealand biotech Rekover Therapeutics for shares and performance rights, adding a planned Phase 2a multiple sclerosis trial to its neurology portfolio. The transaction is paired with a $10 million placement, but would substantially expand the company’s share count and requires shareholder approval.

Mayne Pharma’s unaudited first-quarter revenue fell 2% to A$95.7 million, while underlying EBITDA dropped 52% as generic competition hit Dermatology. Strong prescription growth in Women’s Health and DistributeRx offered a partial counterweight, alongside progress on key legal disputes.

Metallium has signed a non-binding MOU with global commodity trader Traxys to explore feedstock, processing, offtake and financing opportunities for U.S. critical metals. The framework could improve the path to commercial scale, but it contains no binding volumes, prices, funding or sales commitments.

BlueScope Steel has raised its 1H FY2027 underlying EBIT guidance to approaching $1.1 billion, well above its previous $860 million to $960 million range. Stronger US steel spreads are driving the upgrade, with Australian demand also exceeding expectations.

Sarytogan Graphite has completed a 50,000-tonne-a-year upstream graphite DFS and extended copper porphyry exploration in Kazakhstan, but held only A$1.015 million in cash at quarter end. The company estimates that balance represents 0.88 quarters of funding at its recent spending rate, leaving project financing and potential capital raising firmly in focus.

Elevra Lithium has completed the sale of its Ghanaian Ewoyaa project interest to Zhejiang Huayou Cobalt for US$71 million in cash before fees and taxes. The deal removes its development funding obligations and transfers its spodumene offtake rights, leaving the company more focused on its North American portfolio.

Canadian Phosphate has completed 18 Wapiti drill holes and visually traced its phosphate Main Zone across approximately 9km, although laboratory assays are still pending. The company has also completed its Utah acquisition, reported stronger rock phosphate orders and ended September with $3.144 million in cash.

Everest Metals’ Mt Edon project has been selected as Australia’s representative site in a five-year German-funded exploration program and accepted into the European Union’s Raw Materials Mechanism. The recognition may improve access to technical expertise, strategic partners and potential financing, although no funding, offtake or development commitment was announced.

Evion Group has secured mining permits for its flagship Maniry graphite project in Madagascar and signed its first binding supply commitment, while its Nevada fluorspar exploration and Indian downstream operations also advanced. The company ended September with A$5.755 million in cash, but major development milestones still depend on funding, approvals and final agreements.

Sunrise Energy Metals has completed key Syerston engineering work and received a conditional commitment for up to US$400 million in long-term debt from the U.S. Office of Strategic Capital. The project’s revised scope now carries an estimated A$450 million to A$475 million capital cost, while the proposed Nasdaq redomiciliation remains subject to multiple approvals.